Heparin bridging in peri-procedural management of new oral anticoagulant: A bridge too far?

European Heart Journal

Volumn 35, Issue 28, 2014, Pages 1831-1833

  Vanassche, Thomas ^a,b   Lauw, Mandy N ^a,c   Connolly, Stuart J ^a   Eikelboom, John W ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT; ANTIVITAMIN K; APIXABAN; DABIGATRAN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PHENPROCOUMON; RIVAROXABAN; WARFARIN;

ANTICOAGULANT THERAPY; BLEEDING; CLINICAL PRACTICE; DISEASE REGISTRY; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; EDITORIAL; ELECTIVE SURGERY; HEART ATRIUM FIBRILLATION; HIGH RISK PATIENT; HUMAN; LONG TERM CARE; OBSERVATIONAL STUDY; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURGICAL PATIENT; TREATMENT DURATION; VENOUS THROMBOEMBOLISM; CHEMICALLY INDUCED; FEMALE; MALE; OPERATIVE BLOOD LOSS; POSTOPERATIVE HEMORRHAGE; STATISTICS AND NUMERICAL DATA;

ANTICOAGULANTS; BLOOD LOSS, SURGICAL; FEMALE; HEPARIN; HUMANS; MALE; POSTOPERATIVE HEMORRHAGE;

EID: 84905061177     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu034     Document Type: Editorial

References (11)

1. Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, Camm AJ, Weitz JI, Lewis BS, Parkhomenko A, Yamashita T, Antman EM. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: A meta-Analysis of randomised trials. Lancet 2013; doi:10. 1016/S0140-6736(13)62343-0
2. Van Der Hulle T, Kooiman J, Den Exter PL, Dekkers OM, Klok FA, Huisman MV. Effectiveness and safety of novel oral anticoagulants compared with vitamin K-Antagonists in the treatment of acute symptomatic venous thromboembolism-A systematic review and meta-Analysis. J Thromb Haemost 2013; doi:10. 1111/jth. 12485
3. Eikelboom JW, Weitz JI. New anticoagulants. Circulation 2010;121:1523-1532
4. Beyer-Westendorf J, Gelbricht V, Förster K, Ebertz F, Köhler C, Werth S, Kuhlisch E, Stange T, Thieme C, Daschkow K, Weiss N. Peri-interventional management of novel oral anticoagulants in daily care: Results from the prospective Dresden NOAC registry. Eur Heart J 2014;35:1888-1896
5. Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, Dunn AS, Kunz R; American College of Chest Physicians. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141: E326S-e350S.
6. Siegal D, Yudin J, Kaatz S, Douketis JD, Lim W, Spyropoulos AC. Periprocedural heparin bridging in patients receiving vitamin K antagonists: Systematic review and meta-Analysis of bleeding and thromboembolic rates. Circulation 2012;126: 1630-1639
7. Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, Sinnaeve P, Camm AJ, Kirchhof P. EHRA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: Executive summary. Eur Heart J 2013;34:2094-2106
8. Levy JH, Faraoni D, Spring JL, Douketis JD, Samama CM. Managing new oral anticoagulants in the perioperative and intensive care unit setting. Anesthesiology 2013;118: 1466-1474
9. Liew A, Douketis J. Perioperative management of patients who are receiving a novel oral anticoagulant. Intern Emerg Med 2013;8:477-484
10. Healey JS, Brambatti M. Periprocedural management of oral anticoagulation in patients with atrial fibrillation: Approach in the era of new oral anticoagulants. Can J Cardiol 2013;29:S54-S59
11. Healey JS, Eikelboom J, Douketis J, Wallentin L, Oldgren J, Yang S, Themeles E, Heidbuchel H, Avezum A, Reilly P, Connolly SJ, Yusuf S, EzekowitzM; RE-LY Investigators. Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: Results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial. Circulation 2012;126: 343-348.